From the use of robots in surgery to new materials for wound management, from the use of mobile apps to help us all monitor our health to the use of virtual reality to assist people with prosthetic limbs, from the use of AI in diagnostics to 3D printing of organs, technology is changing and enhancing the world of medicine and health care. As a result of the growing imbalance between the demands for health care, our expectation of excellent outcomes, and the ability to deliver these, there is an ever-increasing need for innovation and new approachesto improve the efficiency and cost-effectiveness of services to help bridge the gap.
In January WiTT brought together a panel of experts in this vast and complex field who guided us through some of the latest trends in Medtech developments and provided insights into the use of AI and digital to enhance the way that healthcare is organised and delivered. The event featured a short talk by each panel member, followed by discussion and Q&A.
Our panel was chaired by Annette Nabavi, WiTT board director and NED at Maintel Holdings. She was joined by:
- Pam Garside, Partner at Newhealth, Fellow Judge Business School, University of Cambridge;
- Rayna Patel, Co-Founder, Vine Health;
- Hélène Viatge, CEO, Bioinduction and
- Karen Taylor, Director, Deloitte UK Centre for Health Solutions.
Biographies of our speakers are below.
To watch the panel discussion, please visit the WiTT YouTube Channel.
You can download a copy of Deloitte’s report, “The future awakens: Life Sciences and Health Care Predictions 2022” here.
Speakers and Panel Chair
Board Director, Maintel; WiTT
Annette has a broad range of public and private board experience and currently holds a number of Directorships. She is a Non-Executive Director on the board of Maintel Holdings plc, an AIM listed unified communications services business. She also serves as the Chairman of Maintel’s Remuneration Committee and is a member of the Audit Committee. She is on the Advisory Board of the National Media Museum, part of the Science Museum Group, and a Director of Women in Telecoms and Technology (WiTT) Ltd.
Annette has a broad range of public and private board experience and currently holds a number of Directorships. She is a Non-Executive Director on the board of Maintel Holdings plc, an AIM listed unified communications services business.
She also serves as the Chairman of Maintel’s Remuneration Committee and is a member of the Audit Committee. She is on the Advisory Board of the National Media Museum, part of the Science Museum Group, and a Director of WiTT.
Annette is a Partner with AHV Associates, a firm of corporate finance advisors specializing in Mergers and Acquisitions, Capital Raising, Structured Finance and Derivatives Advisory work for privately owned businesses. She specializes in corporate finance projects for small and medium privately owned enterprises in the IT, technology, telecoms and media sectors.
Annette previously held the position of Head of Telecoms Global Business Development for Corporate Finance at ING Barings where she gained significant experience in M&A, private equity, structured debt and public equity transactions. She later became the founding director and CEO of XchangePoint Holdings Ltd, a Venture Capital backed Internet Interconnect company providing broadband metro peering services to ISPs and network operators. Her early years were spent with the PA Consulting Group where she specialized in strategic partnerships, business planning and marketing strategy. She became a Senior Partner with PA before moving to Barings. Annette holds an MA from Oxford University and a Doctorate from the University of Dijon.
Partner at Newhealth
Fellow, Judge Business School University of Cambridge
Pam Garside has her own management consultancy, Newhealth, specialising in organisational strategy and development in health care, and is a Fellow of the Judge Business School of the University of Cambridge. She advises new entrants to the UK health market including digital and start up companies and is an angel investor. Pam founded and co-chairs The Cambridge Health Network, a membership group of senior players in UK health, both private and public sector. She sits on the Investment Committee of Cambridge Enterprise, the technology transfer company of the University of Cambridge and is a member and board member of Cambridge Angels.She is a board member of Whizz-Kidz charity, ZPB Ltd and a senior adviser to Smith Square Partners.
In 2016 Pam was named one of the 100 most influential leaders in Health Tech by Hot Topics. Pam began her professional life in management in the NHS and subsequently spent many years studying and working internationally based in the USA. She holds a BSc from the University of Durham and a Masters Degree in Hospital and Health Care Administration from the University of Minnesota. She is an Adjunct Professor at Imperial College Business School.
Deloitte UK Centre for Health Solutions
Karen is the Research Director of the Centre for Health Solutions. She supports the Healthcare and Life Sciences practice by driving independent and objective business research and analysis into key industry challenges and associated solutions; generating evidence based insights and points of view on issues from pharmaceuticals and technology innovation to healthcare management and reform. Karen also produces a weekly blog on topical issues facing the healthcare and life science industries.
Hélène is a French engineer from Ecole Polytechnique who has worked in the healthcare sector for over eight years. She started her career at GE Healthcare working on echocardiography equipment, then moved to Sorin to set up a mechanical and electrical simulation center for their Cardiac Rhythm Management BU, and then chose to leave the technical field to do more business-oriented jobs. She worked for one of the biggest French health insurance company in France, in a variety of diverse and challenging roles: project management, business development, sales and marketing (digital and offline, product management), and strategy consultancy.
She moved to the UK three years ago, initially in London working for a digital health start-up Cupris as their COO, then to Bristol where she is now CEO of neurmodulation company Bioinduction. She is passionate about health and innovation.
Rayna is medical doctor with over a decade of experience in healthcare, working in frontline hospitals, national government policy and cognitive neuroscience research. More recently, she and her co-founder, Georgina Kirby, started Vine Health; an AI-driven health technology start-up. Vine Health’s mission is to revolutionise cancer care through behavioural science and artificial intelligence.